News
2d
ZME Science on MSNThis mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 YearsIn a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
7d
Live Science on MSNExperimental HIV vaccines show promise in early safety testSeveral vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
Many people infected with HIV don’t develop those antibody levels, much less people exposed to the various attempted vaccines throughout the decades. But the hope is that an mRNA vaccine could ...
Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021.
The Department of Health and Human Services said it is winding down its mRNA vaccine-development activities under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results